αvβ3 Integrin induces partial EMT independent of TGF-β signaling

[1]  Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.

[2]  A. Jemal,et al.  Cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[3]  N. Altorki,et al.  The lung microenvironment: an important regulator of tumour growth and metastasis , 2018, Nature Reviews Cancer.

[4]  M. Saitoh.  Involvement of partial EMT in cancer progression. , 2018, Journal of biochemistry.

[5]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[6]  Hiroshi I. Suzuki.  MicroRNA Control of TGF-β Signaling , 2018, International journal of molecular sciences.

[7]  Y. Kariya,et al.  Biological role of site-specific O-glycosylation in cell adhesion activity and phosphorylation of osteopontin. , 2018, The Biochemical journal.

[8]  T. Voet,et al.  Identification of the tumour transition states occurring during EMT , 2018, Nature.

[9]  J. Gu,et al.  β4-Integrin/PI3K Signaling Promotes Tumor Progression through the Galectin-3–N-Glycan Complex , 2018, Molecular Cancer Research.

[10]  F. Tang,et al.  Single-cell RNA-seq analysis unveils a prevalent epithelial/mesenchymal hybrid state during mouse organogenesis , 2018, Genome Biology.

[11]  H. Saya,et al.  Prospects for new lung cancer treatments that target EMT signaling , 2018, Developmental dynamics : an official publication of the American Association of Anatomists.

[12]  Roy S. Herbst,et al.  The biology and management of non-small cell lung cancer , 2018, Nature.

[13]  P. Steeg,et al.  Targeting metastasis , 2016, Nature Reviews Cancer.

[14]  E. Ben-Jacob,et al.  Stability of the hybrid epithelial/mesenchymal phenotype , 2016, Oncotarget.

[15]  Jenny G. Parvani,et al.  Silencing β3 Integrin by Targeted ECO/siRNA Nanoparticles Inhibits EMT and Metastasis of Triple-Negative Breast Cancer. , 2015, Cancer research.

[16]  Eshel Ben-Jacob,et al.  Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis , 2015, Front. Oncol..

[17]  Xudong Dai,et al.  Molecular portraits of epithelial, mesenchymal, and hybrid States in lung adenocarcinoma and their relevance to survival. , 2015, Cancer research.

[18]  Eshel Ben-Jacob,et al.  OVOL guides the epithelial-hybrid-mesenchymal transition , 2015, Oncotarget.

[19]  Kwok-Kin Wong,et al.  Non-small-cell lung cancers: a heterogeneous set of diseases , 2014, Nature Reviews Cancer.

[20]  Jing Wang,et al.  An integrin β3–KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibition , 2014, Nature Cell Biology.

[21]  Bogi Andersen,et al.  Mammary morphogenesis and regeneration require the inhibition of EMT at terminal end buds by Ovol2 transcriptional repressor. , 2014, Developmental cell.

[22]  J. Bader,et al.  Twist1-induced dissemination preserves epithelial identity and requires E-cadherin , 2014, The Journal of cell biology.

[23]  F. Rodriguez,et al.  E-cadherin's dark side: possible role in tumor progression. , 2012, Biochimica et biophysica acta.

[24]  C. Heldin,et al.  Regulation of EMT by TGFβ in cancer , 2012, FEBS letters.

[25]  D. Radisky,et al.  MYC Suppresses Cancer Metastasis by Direct Transcriptional Silencing of αv and β3 Integrin Subunits , 2012, Nature Cell Biology.

[26]  W. Franklin,et al.  Loss of Transforming Growth Factor Beta Type II Receptor Increases Aggressive Tumor Behavior and Reduces Survival in Lung Adenocarcinoma and Squamous Cell Carcinoma , 2012, Clinical Cancer Research.

[27]  S. Goodman,et al.  Matched rabbit monoclonal antibodies against αv-series integrins reveal a novel αvβ3-LIBS epitope, and permit routine staining of archival paraffin samples of human tumors , 2012, Biology Open.

[28]  David A. Cheresh,et al.  Integrins in cancer: biological implications and therapeutic opportunities , 2010, Nature Reviews Cancer.

[29]  F. Domann,et al.  ZEB1 Coordinately Regulates Laminin-332 and β4 Integrin Expression Altering the Invasive Phenotype of Prostate Cancer Cells* , 2010, The Journal of Biological Chemistry.

[30]  N. Nagaraj,et al.  Targeting the transforming growth factor-β signaling pathway in human cancer , 2010, Expert opinion on investigational drugs.

[31]  Julia Schüler,et al.  The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs , 2009, Nature Cell Biology.

[32]  D. Tarin,et al.  Integrin αvβ3/c-src “Oncogenic Unit” Promotes Anchorage-independence and Tumor Progression , 2009, Nature Medicine.

[33]  蔡輔仁,et al.  Osteopontin increases lung cancer cells migration via activation of the αvβ3 integrin/FAK/Akt and NF-kB-dependent pathway , 2009 .

[34]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[35]  Diane D. Liu,et al.  Epithelial-to-Mesenchymal Transition in the Development and Progression of Adenocarcinoma and Squamous Cell Carcinoma of the Lung , 2009, Modern Pathology.

[36]  G. Goodall,et al.  The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 , 2008, Nature Cell Biology.

[37]  Xiaohong Liu,et al.  Defective expression of transforming growth factor beta type II receptor (TGFBR2) in the large cell variant of non-small cell lung carcinoma. , 2007, Lung cancer.

[38]  William P Schiemann,et al.  β3 Integrin and Src facilitate transforming growth factor-β mediated induction of epithelial-mesenchymal transition in mammary epithelial cells , 2006, Breast Cancer Research.

[39]  Brian Bierie,et al.  Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis. , 2005, Cancer research.

[40]  Zewei Luo,et al.  Defective Expression of Transforming Growth Factor β Receptor Type II Is Associated with CpG Methylated Promoter in Primary Non-Small Cell Lung Cancer , 2004, Clinical Cancer Research.

[41]  Y. Nakanishi,et al.  The levels of integrin αvβ5 may predict the susceptibility to adenovirus-mediated gene transfer in human lung cancer cells , 1998, Gene Therapy.

[42]  W. Birchmeier,et al.  E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells , 1991, The Journal of cell biology.

[43]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.